home

ALLO.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

symbollastchange%chngnamemcapsectorwiki
ALLO
US
Allogene Therapeutics Inc 1.142B Healthcare

Market global news for ALLO (US) Allogene Therapeutics

Global news - US chevrons indicate local prediction, arrows show global predictions
Today
previous days
Allogene Therapeutics Presents Data on Dagger™, a Next Generation AlloCAR T™ Platform Technology
tmcnet - 20:30 Wed 1 - ALLO - link story
Allogene Therapeutics Presents Data on Dagger™, a Next Generation AlloCAR T™ Platform Technology
yahoo - 20:30 Wed 1 - ALLO - link story
Allogene Therapeutics Presents Data on Dagger™, a Next Generation AlloCAR T™ Platform Technology
streetinsider - 20:15 Wed 1 - ALLO - link story
Allogene Therapeutics Presents Data on Dagger™, a Next Generation AlloCAR T™ Platform Technology
streetinsider - 20:15 Wed 1 - ALLO - link story
Stock Market | FinancialContent Business Page
financialcontent - 20:15 Wed 1 - ALLO - link story
Allogene Therapeutics Publishes Preclinical Data in Clinical Cancer Research Supporting DLL3 as a Potential AlloCAR T™ Target for Small Cell Lung Cancer
streetinsider - 17:00 Wed 25 - ALLO - link story
Allogene Therapeutics (ALLO) Announces Publication Supporting DLL3 as a Potential AlloCAR T Target
streetinsider - 14:15 Wed 25 - ALLO - link story
Stock Market | FinancialContent Business Page
financialcontent - 13:45 Wed 25 - ALLO - link story
Why Allogene Therapeutics Shares Are Seeing Blue Skies Today
businessinsider - 18:00 Tue 24 - ALLO - link story
Allogene Therapeutics Shares Up 13% on Publication of ALLO-715 Trial Data
marketwatch - 17:15 Tue 24 - ALLO - link story
Allogene Therapeutics Announces Publication in Nature Medicine of Data from its Phase 1 UNIVERSAL Study of ALLO-715 for the Treatment of Relapsed/Refractory Multiple Myeloma
wallstreet-online de - 16:45 Tue 24 - ALLO - link story
Allogene Therapeutics (ALLO) Announces Publication of Data from its Phase 1 UNIVERSAL Study of ALLO-715
streetinsider - 15:45 Tue 24 - ALLO - link story
Moore Kuehn, PLLC Encourages Investors of Allogene
globenewswire - 04:15 Mon 23 - ALLO - link story
Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences
tmcnet - 00:00 Wed 18 - ALLO - link story
Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences
yahoo - 21:45 Tue 17 - ALLO - link story
Acquisition of Neogene Therapeutics completed
pharmiweb - 12:45 Tue 17 - ALLO - link story
Moore Kuehn, PLLC Encourages Investors of Allogene Therapeutics, Inc. to Contact Law Firm
prnewswire - 18:30 Thu 5 - ALLO - link story
Allogene Appoints Zachary J. Roberts, M.D., Ph.D. as Executive Vice President of Research & Development
tmcnet - 13:30 Tue 3 - ALLO - link story